| Takeda Pharma AG - Fruzaqla 5 mg, Hartkapseln | | 69524 | | 02 | | Fruzaqla 5 mg | | Hartkapseln | | L01EK04 | | | | 27.08.2024 | | |
| | Composition | | fruquintinibum 5 mg, maydis amylum, cellulosum microcristallinum, talcum, Kapselhülle: gelatina, E 171, E 133, E 129 0.1829 mg, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Fruquintinibum | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Fruquintinibum | 5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Cellulosum Microcristallinum | | | | E 129 | 0.1829 mg | color. | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Maydis Amylum | | | | Pro Capsula | | | | Propylenglycol | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 21 | 3782.91 | 4130.55 | A | LS | Non |
|
|
